CNMD CONMED Corp

Price (delayed)

$142.26

Market cap

$4.14B

P/E Ratio

309.26

Dividend/share

$0.8

EPS

$0.46

Enterprise value

$4.85B

Sector: Healthcare
Industry: Medical Devices

Highlights

The stock's price to earnings (P/E) is 82% less than its last 4 quarters average of 1739.1 and 24% less than its 5-year quarterly average of 402.0
The company's debt fell by 5% YoY
CNMD's EPS has shrunk by 61% YoY but it is up by 39% QoQ
The net income has dropped by 60% year-on-year but it is up by 41% since the previous quarter
CNMD's quick ratio is down by 8% YoY
CNMD's gross margin is down by 3.1% YoY

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
29.09M
Market cap
$4.14B
Enterprise value
$4.85B
Valuations
Price to earnings (P/E)
309.26
Price to book (P/B)
5.67
Price to sales (P/S)
4.68
EV/EBIT
92.06
EV/EBITDA
68.46
EV/Sales
5.5
Earnings
Revenue
$881.13M
EBIT
$52.65M
EBITDA
$70.81M
Free cash flow
$73.08M
Per share
EPS
$0.46
Free cash flow per share
$2.52
Book value per share
$25.07
Revenue per share
$30.41
TBVPS
$21.9
Balance sheet
Total assets
$1.75B
Total liabilities
$1.02B
Debt
$745.4M
Equity
$725.57M
Working capital
$242.21M
Liquidity
Debt to equity
1.03
Current ratio
2.33
Quick ratio
1.1
Net debt/EBITDA
10.01
Margins
EBITDA margin
8%
Gross margin
53.3%
Net margin
1.5%
Operating margin
6%
Efficiency
Return on assets
0.8%
Return on equity
1.9%
Return on invested capital
4.5%
Return on capital employed
3.4%
Return on sales
6%
Dividend
Dividend yield
0.56%
DPS
$0.8
Payout ratio
173.9%

CNMD stock price

How has the CONMED stock price performed over time
Intraday
1.09%
1 week
-0.97%
1 month
9.05%
1 year
118.86%
YTD
27.02%
QTD
8.94%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$881.13M
Gross profit
$469.59M
Operating income
$52.65M
Net income
$13.45M
Gross margin
53.3%
Net margin
1.5%
The net income has dropped by 60% year-on-year but it is up by 41% since the previous quarter
The company's net margin has shrunk by 57% YoY but it rose by 36% QoQ
The operating income has declined by 34% year-on-year but it has increased by 15% since the previous quarter
The operating margin has declined by 29% year-on-year but it has grown by 13% since the previous quarter

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
P/E
309.26
P/B
5.67
P/S
4.68
EV/EBIT
92.06
EV/EBITDA
68.46
EV/Sales
5.5
The stock's price to earnings (P/E) is 82% less than its last 4 quarters average of 1739.1 and 24% less than its 5-year quarterly average of 402.0
CNMD's EPS has shrunk by 61% YoY but it is up by 39% QoQ
The stock's price to book (P/B) is 81% more than its 5-year quarterly average of 3.1 and 40% more than its last 4 quarters average of 4.0
CNMD's equity is up by 3.4% YoY and by 2.3% from the previous quarter
CNMD's P/S is 93% more than its 5-year quarterly average of 2.4 and 45% more than its last 4 quarters average of 3.2
CNMD's revenue is down by 7% year-on-year but it is up by 2.2% since the previous quarter

Efficiency

How efficient is CONMED business performance
CNMD's return on assets has surged by 60% since the previous quarter but it has dropped by 58% year-on-year
The ROE has plunged by 60% YoY but it has grown by 36% from the previous quarter
CNMD's return on invested capital is down by 32% year-on-year but it is up by 18% since the previous quarter
CNMD's ROS is down by 29% YoY but it is up by 13% QoQ

Dividends

What is CNMD's dividend history
DPS
$0.8
Dividend yield
0.56%
Payout ratio
173.9%
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 71% greater than its total liabilities
CNMD's quick ratio is down by 8% YoY
The current ratio has grown by 6% from the previous quarter but it has contracted by 5% YoY
The company's debt is 2.7% higher than its equity
The company's debt to equity fell by 8% YoY and by 2.8% QoQ
The company's debt fell by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.